PuriflOH (ASX: PO3) Share Price and News
Price
$0.22
Movement
– ( )
as at 18 Feb - Closed (20 mins delayed)
52 Week Range
– - –
1 Year Return
0.0
PuriflOH Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$0.22
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
$0.22
Today's Open
–
Days Range
– - –
Volume
0
Avg. Volume (1 month)
0
Turnover
$0
as at 18 Feb - Closed
PuriflOH (ASX: PO3)
Latest News

Share Market News
Why the Purifloh (ASX:PO3) share price leapt 12% today

Share Market News
Purifloh (ASX:PO3) shares enter trading halt after surging 24%

Share Market News
ASX stock of the day: Purifloh (ASX:PO3) shares surge 22% on update

52-Week Lows
Why the Purifloh (ASX:PO3) share price crashed to a 2-year low today
Share Market News
PuriflOH share price soars 19% on OTC listing announcement
PO3 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
17th Feb 2025 2025-02-17T19:57:07 | Confirmation of delisting | YesNo | 7:57pm | 1 | 120k |
17th Feb 2025 2025-02-17T08:51:49 | Removal from Official List | YesNo | 8:51am | 1 | 116k |
31st Jan 2025 2025-01-31T15:52:15 | Quarterly Activities/Appendix 4C Cash Flow Report | YesNo | 3:52pm | 8 | 1.1M |
30th Jan 2025 2025-01-30T08:45:42 | Proposed issue of securities - PO3 | YesNo | 8:45am | 8 | 27k |
29th Jan 2025 2025-01-29T15:33:08 | Notice of General Meeting/Proxy Form | YesNo | 3:33pm | 74 | 1.1M |
22nd Jan 2025 2025-01-22T16:20:01 | Long Term Suspended Entities | YesNo | 4:20pm | 8 | 206k |
29th Nov 2024 2024-11-29T13:31:45 | 2024 AGM - Results of meeting | YesNo | 1:31pm | 2 | 169k |
29th Nov 2024 2024-11-29T13:31:30 | 2023 AGM - Results of meeting | YesNo | 1:31pm | 2 | 166k |
6th Nov 2024 2024-11-06T12:02:11 | Response to ASX Query | YesNo | 12:02pm | 12 | 427k |
31st Oct 2024 2024-10-31T14:28:36 | Quarterly Activities/Appendix 4C Cash Flow Report | YesNo | 2:28pm | 7 | 1.1M |
About PuriflOH
Purifloh Ltd. engages in the provision of chemical free indoor air purification, water sanitation and surface sterilization solutions. The company was founded by Brian L. Harcourt on March 15, 2007 and is headquartered in South Melbourne, Australia.
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Simon Richard Lill | Non-Executive Director | Mar 2024 |
Mr. Lill has a background of over 30 years of stockbroking, capital raising, management, business development and analysis for a range of small and start-up companies, in both the manufacturing and resources industries. He has assisted Mr. Le Souef in the restructuring of the Company in 2013 and has managed the Company's Australian affairs since that time. He has similarly assisted the restructure of De Grey Mining Limited from his appointment in 2013 and is now Chairman of that Company.
|
Dr Alex Sava | Non-Executive Director | Apr 2021 |
Dr Sava was the inventor of the aerosol hydrogen peroxide disinfection process ('nanonebulant'), that became a core technology of ASX200 company, Nanosonics Limited (NAN.ASX), Dr. Sava also has experience commercializing his inventions in numerous international markets. This has provided Dr Sava with strong regulatory and commercial experience which will be of specific relevance to the Company as it embarks on commercial execution.
|
Mr Carl Le Souef | Non-Executive DirectorInterim Chairman | Nov 2019 |
Mr.Le Souef is a founding partner and co-owner of Somnio Global. He oversaw the restructuring of PuriflOH (previously known as Water Resources Group Limited) during 2013/2014, which resulted in Dilato Holdings Pty Limited emerge as the major shareholder of PuriflOH, a position it still retains. Dilato Holdings is Mr. Le Souef's private investment company. Mr. Le Souef was previously the sole owner and CEO of one of Australia's largest privately owned FMCG organizations, Private Formula International, a global operation that included Australia's number one selling skincare range at the time, Dr LeWinn's Private Formula. In 2009, he negotiated the sale of the Company to a US based pharmaceutical major. Mr. Le Souef maintains an executive role in Somnio Global and in the management of his family office investments.
|
Mr Adam John Gallagher | Company Secretary | Mar 2024 |
-
|
Adam John Gallagher | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Dilato Holdings Pty Ltd | 18,409,194 | 57.23% |
Upjohn Laboratories Llc | 5,271,601 | 16.39% |
Andra M Rush | 650,000 | 2.02% |
Riveck Nominees Pty Ltd | 487,000 | 1.51% |
Flue Holdings Pty Ltd | 306,000 | 0.95% |
Gemtara Investments Pty Ltd | 305,576 | 0.95% |
Citicorp Nominees Pty Limited | 289,167 | 0.90% |
Anthony Mark Van Der Steeg | 282,446 | 0.88% |
Richard Li Ming Chan | 260,000 | 0.81% |
Arpitha Pradeep | 250,000 | 0.78% |
Targo Holdings Pty Ltd | 245,250 | 0.76% |
Birch & Associates Pty Ltd | 236,262 | 0.73% |
Steven Annear | 224,278 | 0.70% |
Malcolm Richmond | 159,965 | 0.50% |
HSBC Custody Nominees (Aus) Limited | 148,786 | 0.46% |
Isamg Pty Ltd | 135,850 | 0.42% |
Credal International Ltd | 113,895 | 0.35% |
Alexei Sava | 100,000 | 0.31% |
Ranchland Holdings Pty Ltd | 100,000 | 0.31% |
Jeremy Stone | 93,429 | 0.29% |
Saul Zaidman | 86,050 | 0.27% |